Reconstitution of the adaptive immune system following allogeneic hematopoietic stem cell transplantation is crucial for beneficial outcome and is affected by several factors, such as GvHD and graft source. The impact of these factors on immune reconstitution has been thoroughly investigated during the early phase after transplantation. However, little is known about their long-term effect. Similarly, leukocyte telomere length (TL) shortening has been reported shortly after transplantation. Nevertheless, whether TL shortening continues in long-term aspect is still unsettled. Here, we assessed T-cell receptor excision circle (TREC), kappa deleting recombination excision circle (KREC) and leukocyte TL in recipients and donors several years post transplantation (median 17 years). Our analysis showed that, recipients who received bone marrow (BM) as the graft source have higher levels of both TREC and KREC. Also, chronic GvHD affected TREC levels and TL but not KREC levels. Finally, we show that recipient's TL was longer than respective donors in a group of young age recipients with high KREC levels. Our results suggest that BM can be beneficial for long-term adaptive immune recovery. We also present supporting evidence for recipient telomere homeostasis, especially in young age recipients, rather than telomere shortening.
INTRODUCTION
Allogeneic hematopoietic stem cell transplantation (AHSCT) has become a well-established therapeutic strategy for several hematological disorders. 1 Following transplantation, patients encounter a critical state of immunodeficiency that accounts for significant morbidity and mortality. 2 Reconstitution of adaptive immunity after AHSCT is crucial for beneficial outcome and requires continuous generation of new T and B cells, together that are able to maintain their proliferative capacity. This entails active contribution of both the thymus and bone marrow (BM) in terms of thymopoeisis and B-cell neogenesis, respectively.
Transplantation-related factors, especially graft source and GvHD, can affect recovery of adaptive immunity. Several studies have shown the impact of these factors on thymic recovery during the early phase post HSCT. [3] [4] [5] [6] [7] [8] [9] [10] Nevertheless, whether these effects are transient or persist for several years after transplantation has not been thoroughly investigated. Furthermore, the long-term impact of these factors on B-cell neogenesis is largely unknown.
T-cell receptor excision circles (TRECs) are generated during T-cell receptor (TCR) gene rearrangement, and represents a reliable marker for thymic output. 8, 11 Similarly, BM B-cell output can be monitored by measuring the kappa deleting recombination excision circle (KREC) that is generated in B-cell progenitors during Ig light chain rearrangement. 12 A telomere is a tandem-repeated nucleotide hexamer located at the ends of linear chromosomes. 13 The telomere length (TL)
reflects the replicative capacity of cells as TL shortens in somatic cells, including leukocytes, with each round of cell division. 14 In context of AHSCT, several studies showed accelerated TL shortening of recipients leukocytes shortly after transplantation. 15, 16 However, whether TL shortening continues in the long term which, in theory, can lead to premature senescence of immune cells remains unsettled, as several studies have shown inconsistent results. [17] [18] [19] In this study, our goal was to highlight the pattern of recovery of TREC and KREC molecules in long-term survivors, and to address whether or not transplantation-related factors have a persistent impact on immune reconstitution. Furthermore, we addressed whether TL shortening continues in recipients in the long term and showed a potential relationship with transplantation-related factors and with TREC and KREC.
SUBJECTS AND METHODS

Patients and controls
Sixty-three recipients who underwent AHSCT prior to 2005, and 41 donors, were enrolled in this study. Of which, 31 recipients and donors were matched siblings. Patient characteristics are shown in Table 1 . With the exception of six patients none of the recipients was under immune suppressive treatment at the time of sampling. Individuals defined with chronic GVHD were all resolved at time of the study except the same six individuals that were under immune suppressive treatment.
TREC and KREC quantification
Genomic DNA was extracted from peripheral blood mononuclear cells using EZ1 DNA Blood Kit and EZ1 instruments (Qiagen, Hilden, Germany) and stored at − 20°C till the time of analysis. TREC, KREC and β-actin (ACTB) as a reference gene were amplified simultaneously by triplex TaqMan real-time PCR as described previously, 20 using SCREEN ID kit (Mabtech Diagnostics AB, Stockholm, Sweden). For more details, see supplementary information.
Measuring telomere length telomere length was assessed by relative quantification of telomere DNA to DNA of a single copy gene (T/S) as described before. 21 For more details, see supplementary information.
Flow cytometry peripheral blood mononuclear cells were isolated from fresh heparinized blood by density gradient centrifugation (Lymphoprep, Fresenius Kabi, Oslo, Norway) and stored in liquid nitrogen freezer till the time of analysis. Staining was done as previously described. 22 antibodies that were used are listed in Supplementary table S1. data acquisition was performed on FACS CANTO instrument using FACS Diva software (BD Biosciences, Franklin Lakes, NJ, USA) and data were analyzed using FlowJo V10 (TreeStar, Ashland, OR, USA). Gating strategy is shown in Supplementary  Figure S1 . Abbreviations: ALL = acute lymphoblastic leukaemia; AML = acute myeloid leukaemia; aGvHD = acute graft versus host disease; ATG = anti-thymocyte globulin; BM = bone marrow; cGvHD = chronic graft versus host disease; ChL = Hodgkin lymphoma; CLL = chronic lymphocytic leukaemia; CML = chronic myeloid leukaemia; CsA = cyclosporine A; MAC = myeloablative conditioning; MDS = myelodysplastic syndrome; MM = multiple myeloma; MMF = mycophenolate mofetil; MTX = methotrexate; PBSC = peripheral blood stem cells; RIC = reduced intensity conditioning; others* = non-malignant causes (Fanconi, SAA, Metabolic, MyeloFibrosis). ) respectively, P = 0.02) while there was no difference in KREC levels between recipients and donors (median (IQR) = 66.6 (41.6-102.1) vs 57.3 (39.6-79.6) respectively, P = 0.3) (Supplementary Table S2 ). We used the median of recipient TREC/ KREC as cut-off point. Accordingly, 14 recipients (28.6%) had TREC and KREC levels above median values, that is, high TREC high KREC (HTHK), 14 recipients (28.6%) had TREC and KREC below medians, that is, low TREC low KREC (LTLK), 11 recipients (22.4%) with high TREC only, that is, high TREC low KREC (HTLK) and 10 recipients (20.4%) with high KREC only, that is, low TREC high KREC (LTHK).
Age was significantly different across the four TREC/KREC groups (P = 0.003) ( Figure 1a) ; recipients in HTHK group had significantly lower age compared to recipients in LTLK group (median = 14 vs 47.5 respectively, P = 0.002). Also, a significant difference in the proportions of BM and PBSC graft source across the four groups was found (P = 0.002) (Figure 1b) . Furthermore, the proportion of recipients with history of moderate/severe chronic GvHD (cGVHD) was higher in LTLK group than HTHK group (57.1% vs 14.3% respectively) ( Figure 1c) .
Recipient TREC and KREC levels were inversely correlated with the age of the recipients (r s = − 0.508, P = 0.0002 and r s = − 0.393, P = 0.001, respectively), but were positively correlated with TREC and KREC of their respective matched donors (r s = 0.549, P = 0.01 and r s = 0.543, P = 0.002, respectively) (Supplementary Figures S2 A-D, Supplementary Table S3) .
In order to confirm the molecular results, peripheral blood mononuclear cell samples from 10 matched recipient/donor pairs were analyzed by flow cytometry. In line with molecular results of Assessment of adaptive immune system after allogeneic HSCTTREC and KREC, frequencies of both naïve CD4 + and CD8 + T cells were lower in recipients than donors (P = 0.009 and P = 0.01, respectively). Additionally, there was no significant difference in the proportions of naïve B cells between recipients and their respective donors (P = 0.09) (Figures 2a-c) .
Relationship between TREC, KREC and cGvHD We showed that the ratio of moderate/severe cGvHD was lower in HTHK group (14.3%) than LTLK group (57.1%), with a relative risk of 0.25 (P = 0.04). Furthermore, there was a significant (threefold) increase in TREC levels in recipients with history of no/mild cGvHD (n = 30) compared to recipients with history of moderate/ severe cGvHD (n = 19), (median (IQR) = 3. Table S4 , Figure 3b) . No significant association between TREC/KREC levels and acute GvHD (aGvHD) was found (Supplementary Table S4 ).
Effect of graft source and conditioning regimen on TREC and KREC We compared TREC/KREC levels in BM and PBSC graft recipients. TREC levels were higher in the BM group compared to PBSC group The results also showed that median TREC levels were significantly lower in recipients who received RIC regimen than in MAC recipients (P = 0.02). This was also noted in KREC although it did not reach a significant value (P = 0.06) (Supplementary Table S4 , Figures 3c and d) .
Transplantation-related factors and TL
We assessed TL in all recipients and in matched donors. There was a negative correlation between TL in recipients and age (r s = − 0.256 and P = 0.04). Also, TL was correlated between recipients and their respective donors (r s = 0.559 and P = 0.001) (Supplementary Table S3 , Supplementary Figures S2E and F) . Furthermore, TL was significantly shorter in recipients with history of moderate/severe cGvHD (n = 23) compared to recipients with no cGvHD (n = 14) (median (IQR) = 0.528 (0.320-1.354) vs 1.534 (0.921-1.888) respectively, P = 0.03) (Supplementary Table S4, Figure 3e ). Remarkably, median TL was shorter in RIC and PBSC recipients (0.383 and 0.509, respectively) than MAC and BM recipients (0.901 and 1.134, respectively) (Supplementary Table S4, Figure 3f) . We also observed a tendency for shorter TL in male recipients who had received a graft from a female donor (n = 19) compared to TL of other recipients (n = 44) (median Table S5 ).
Multivariable analysis
When performing a multivariate analysis with the four parameters cGvHD, graft source, conditioning and recipient age, the effect of recipient age was significant for TREC and KREC levels (P = 0.004 and P = 0.01 respectively), whereas a trend for lower TREC levels was found in patients with history of moderate/severe cGvHD (P = 0.06) ( Table 2 ). Though when these factors were entered using backwards elimination method, the effect of cGvHD becomes significant for TREC (P = 0.017) (Supplementary Table S6 ). Neither graft source nor conditioning regimen were significant according to the multivariable model.
TL in donors and recipients
When examining the whole cohort, there was no significant difference in TL between recipients (n = 63) and donors (n = 31) (median (IQR) = 0.847 (0.383-1.514) vs 0.777 (0.287-1.214), P = 0.3) (Figure 4b , Supplementary Table S2 ). However, a significant difference in TL between recipients and their respective donors was found (n = 31, P = 0.03) (Figure 4c ). To further investigate this finding, recipients and their matched donors were split into two groups according to relation of TL between recipient and donor; group 1 (n = 19) comprised recipients whose TL was longer than the respective donors, and group 2 with recipients TL being shorter than the respective donors (n = 12). Supplementary Table S7 shows the main characteristics of both groups. To confirm that the difference between recipients and respective donors was specifically due to a change in TL of recipients (and not a change in the TL of donors), we compared TL between the recipients of the two groups and also between the donors of the two groups (Figure 4d ). TL was only significantly different between the recipients and not between the donors.
Next, we compared TREC and KREC levels between recipients of both groups (Figures 5a and b) . TREC levels only were significantly higher in group 1 recipients compared to group 2 recipients (P = 0.01). We also compared TREC and KREC levels between recipients and their respective donors in both groups. TREC levels were lower in recipients than donors both in group 1 (P = 0.06) and in group 2 (P = 0.05) (Figures 5c and d) . Interestingly, KREC levels were higher in recipients than respective donors only in group 1 that contained recipient with longer TL (P = 0.06) (Figures 2e and f) .
DISCUSSION
Immune reconstitution in very long-term survivors (median 17 years) after AHSCT has not been, so far, assessed using TREC, KREC and TL. Here, we show that, in contrast to B-cell recovery, recipients' thymic recovery was incomplete, suggesting that thymic recovery is a slow process or probably never achieved. Storek et al. 23 showed persistent, impaired TREC recovery in patients 20 years after transplantation. Another study showed earlier recovery of sjKREC and cjKREC before TREC recovery after transplantation. 24 TREC and KREC recovery were not correlated as we observed recipients with either HTLK or LTHK. In their study, Sottini et al. 20 showed that TREC and KREC recovery following HSCT in primary immunodeficiency patients can be strictly associated or independent from each other. Similarly, Nakatani et al. 24 observed a group of HSCT patients who recovered KREC but not TREC. This variation in recovery pattern suggests that transplantation-related factors exert asymmetrical effects on thymus and BM.
In our study, the effect of recipient age was apparent on TREC, KREC levels and TL. Recipient TREC and TL were further affected by cGvHD. Additionally, BM as graft source was associated with higher levels of TREC and KREC levels late after HSCT. However, in multivariable analysis, recipient age was the only significant factor associated with TREC and KREC levels. There was also an additional strong trend for an influence of cGVHD on TREC levels. Therefore, further studies (preferably multicenter studies) would be preferred to confirm our findings.
Several hypotheses have been postulated to explain the association between GvHD and low TREC levels after AHSCT. 6, 10, 25 In our study, most of the recipients were cGvHD resolved at time of analysis suggesting that the effect of the cGvHD on thymic tissue persists and is most probably irreversible. Conversely, aGvHD did not show a similar long-term effect, suggesting that its impact might be reversible. In this regard, our findings are in agreement with Jiménez et al. 10 Another study by Clave et al. showed a transient effect for aGvHD on thymic recovery in young patients after HSCT. Abbreviations: cGvHD = chronic graft versus host disease; CI = confidence interval; HR = hazard ratio; KREC = kappa deleting recombination excision circle; PBSC = peripheral blood stem cells; RIC = reduced intensity conditioning; TL = telomere length; TREC = T-cell receptor excision circle.
Assessment of adaptive immune system after allogeneic HSCTSeveral studies have shown that aGvHD can suppress B-cell recovery through various mechanisms, including cytokines, stromal cell destruction or treatment itself. 26, 27 Mensen et al.
12
showed that delayed B-cell recovery in AHSCT patients with aGvHD was associated with donor T-cell infiltration of the BM and loss of osteoblasts. Nevertheless, the effect of cGvHD on B-cell recovery has not been thoroughly investigated. In our study, neither aGvHD nor cGvHD affected the KREC levels, suggesting that the long-term effect of cGvHD is more prominent on T cell than B-cell development. . Relationship between TREC, KREC and TL. Recipient/donor pairs (n = 31) were split into two groups*. TREC levels (a) and KREC levels (b) are compared between group 1 recipients and group 2 recipients. TREC levels are compared between recipients and their matched donors in group 1 (c) and in group 2 (d). KREC levels are compared between recipients and their respective donors in group 1 (e) and group 2 (f).
Figures are presented as scatter plots, median and IQR are indicated by horizontal lines. *Recipients and their respective donors were split into two groups according to relation of TL between recipient and donor; group 1 (n = 19) includes recipients with TL4respective donors; group 2 (n = 12) includes recipients with TL orespective donors.
The role of graft source in TREC and KREC recovery is not fully resolved. Our group and others have previously reported better immune reconstitution in BM graft recipients shortly after allogeneic HSCT. 28 To our knowledge, this is the first study to report beneficial effect of BM as a graft source on both TREC/KREC recovery in a long-term aspect. This finding suggests that graft source is not only essential for the early recovery of adaptive immunity, but also for long-lasting immune reconstitution.
The effect of preconditioning regimen on immune recovery after AHSCT is still under debate. 3, 28, 29 The number of RIC recipients in our study was limited (n = 11). Moreover, RIC was initially designed for older age and high-risk groups. 1 In agreement with Baerlocher et al., 19 we show that recipient age and cGvHD have significant impact on leukocyte TL. As females are expected to have longer TL than males, it could be speculated that TL in recipients of female donors would be longer than recipients of male donors. In our study, however, no difference was found between recipients when comparing by donor gender. Neither did we find a difference in TL between genders in the 31 donors included in the study. Interestingly, we show that male recipients with female donors possess the shortest TL. A simple explanation for this is that the risk for GvHD is known to be higher in male recipients with female donors, 30 though other factors such as sex hormones may have a role.
In this study, a group of recipients had TL longer than their respective donors. Remarkably, younger age and higher levels of TREC were the two main noticeable features between recipients with longer TL (group 1) compared to recipients with shorter TL (group 2). It was previously reported that naïve T cells have longer TL than the memory T cells. 18 Accordingly, it can be speculated that high TREC levels in group 1 recipients account for their longer TL compared to group 2 recipients. However, group 1 donors were of the same age and their TREC levels were even higher than recipients. Interestingly, we show higher KREC levels in recipients than respective donors in group 1. It has been shown that B cells have higher telomerase activity as well as longer TL, 31 ,32 which could explain this finding.
Worth mentioning, assessment of TL in different cellular subsets prior to transplantation would be of interest to better alleviate the relationship between recipient and donor TL. Moreover, other aspects such as genetics, life style, hormonal and environmental factors could be considered.
Importantly, assessing TL by qPCR alone could be considered a limitation in our study. Measurement errors are relatively high due to pipetting errors, copy number variation and non-specific amplification. 33 In order to remedy this, careful reaction optimization and performing and checking quality controls are crucial steps. Additionally, validation of results by an additional wellstandardized method is recommended.
In conclusion, we show that BM graft can be beneficial for longterm immune recovery and that cGvHD effect on thymic recovery may persist for several years. Furthermore, we present support for the hypothesis of telomere homeostasis in the long term. Further investigations are needed to support our findings
